Creatine supplementation lowers brain glutamate levels in Huntington's disease

Bender, A.; Auer, D. P.; Merl, T.; Reilmann, R.; Saemann, P.; Yassouridis, A.; Bender, J.; Weindl, A.; Dose, M.; Gasser, T.; Klopstock, T.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Creatine supplementation lowers brain glutamate levels in Huntington's disease

MPS-Authors

/persons/resource/persons80257

Auer, D. P.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80441

Merl, T.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80505

Saemann, P.
AG Czisch, Michael, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80601

Yassouridis, A.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80266

Bender, J.
AG Deussing, Jan, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Bender, A., Auer, D. P., Merl, T., Reilmann, R., Saemann, P., Yassouridis, A., et al. (2005). Creatine supplementation lowers brain glutamate levels in Huntington's disease. Journal of Neurology, 252(1), 36-41.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9B4F-E

Abstract

There is no abstract available